Chris Bodine is an Advisory Partner for NewSpring’s dedicated healthcare funds. Chris has over 35 years of experience with a strong background in retail and healthcare.
Prior to joining the NewSpring team, Chris was President at CVS Caremark (NYSE:CVS), Director at Allergan (NYSE:AGN), and Director at Nash Finch Company. Previously, Chris was a Managing Partner at BTN Development.
Chris holds an Honorary Doctorate Degree in Business Administration from Johnson and Wales University.